102 related articles for article (PubMed ID: 38747501)
1. Genotoxicity associated with retroviral CAR transduction of ATM-deficient T cells.
Rozenbaum M; Fluss R; Marcu-Malina V; Sarouk I; Meir A; Elitzur S; Zinger T; Jacob-Hirsch J; Glick Saar E; Rechavi G; Jacoby E
Blood Cancer Discov; 2024 May; ():. PubMed ID: 38747501
[TBL] [Abstract][Full Text] [Related]
2. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
3. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair.
Mian E; Wiesmüller L
Methods Mol Biol; 2017; 1599():317-334. PubMed ID: 28477129
[TBL] [Abstract][Full Text] [Related]
5. ATM prevents unattended DNA double strand breaks on site and in generations to come.
Yin B; Savic V; Bassing CH
Cancer Biol Ther; 2007 Dec; 6(12):1837-9. PubMed ID: 18087222
[TBL] [Abstract][Full Text] [Related]
6. Expression of ATM in ataxia telangiectasia fibroblasts rescues defects in DNA double-strand break repair in nuclear extracts.
Li Y; Carty MP; Oakley GG; Seidman MM; Medvedovic M; Dixon K
Environ Mol Mutagen; 2001; 37(2):128-40. PubMed ID: 11246219
[TBL] [Abstract][Full Text] [Related]
7. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
Bredemeyer AL; Sharma GG; Huang CY; Helmink BA; Walker LM; Khor KC; Nuskey B; Sullivan KE; Pandita TK; Bassing CH; Sleckman BP
Nature; 2006 Jul; 442(7101):466-70. PubMed ID: 16799570
[TBL] [Abstract][Full Text] [Related]
8. Role of chromatin structure modulation by the histone deacetylase inhibitor trichostatin A on the radio-sensitivity of ataxia telangiectasia.
Meschini R; Morucci E; Berni A; Lopez-Martinez W; Palitti F
Mutat Res; 2015 Jul; 777():52-9. PubMed ID: 25942615
[TBL] [Abstract][Full Text] [Related]
9. Rare Germline
Lampson BL; Gupta A; Tyekucheva S; Mashima K; Petráčková A; Wang Z; Wojciechowska N; Shaughnessy CJ; Baker PO; Fernandes SM; Shupe S; Machado JH; Fardoun R; Kim AS; Brown JR
J Clin Oncol; 2023 Feb; 41(5):1116-1128. PubMed ID: 36315919
[TBL] [Abstract][Full Text] [Related]
10. Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
Di Siena S; Campolo F; Gimmelli R; Di Pietro C; Marazziti D; Dolci S; Lenzi A; Nussenzweig A; Pellegrini M
Cell Death Dis; 2018 Feb; 9(3):314. PubMed ID: 29472706
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chromosomal aberrations and γH2A.X foci to identify radiation-sensitive ataxia-telangiectasia patients.
Bucher M; Endesfelder D; Roessler U; Borkhardt A; Dückers G; Kirlum HJ; Lankisch P; Oommen PT; Niehues T; Rübe CE; Baumgartner I; Bunk F; Moertl S; Hornhardt S; Gomolka M
Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503301. PubMed ID: 33551102
[TBL] [Abstract][Full Text] [Related]
12. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
[TBL] [Abstract][Full Text] [Related]
13. Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.
Sun J; Huye LE; Lapteva N; Mamonkin M; Hiregange M; Ballard B; Dakhova O; Raghavan D; Durett AG; Perna SK; Omer B; Rollins LA; Leen AM; Vera JF; Dotti G; Gee AP; Brenner MK; Myers DG; Rooney CM
J Immunother Cancer; 2015; 3():5. PubMed ID: 25734008
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia: a review.
Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains.
Weizman N; Shiloh Y; Barzilai A
J Biol Chem; 2003 Feb; 278(9):6741-7. PubMed ID: 12496286
[TBL] [Abstract][Full Text] [Related]
16. 53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation.
Rybanska-Spaeder I; Reynolds TL; Chou J; Prakash M; Jefferson T; Huso DL; Desiderio S; Franco S
Mol Cancer Res; 2013 Oct; 11(10):1223-34. PubMed ID: 23858098
[TBL] [Abstract][Full Text] [Related]
17. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions enhance virus-free generation of
Kath J; Du W; Pruene A; Braun T; Thommandru B; Turk R; Sturgeon ML; Kurgan GL; Amini L; Stein M; Zittel T; Martini S; Ostendorf L; Wilhelm A; Akyüz L; Rehm A; Höpken UE; Pruß A; Künkele A; Jacobi AM; Volk HD; Schmueck-Henneresse M; Stripecke R; Reinke P; Wagner DL
Mol Ther Methods Clin Dev; 2022 Jun; 25():311-330. PubMed ID: 35573047
[TBL] [Abstract][Full Text] [Related]
19. Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts.
Garg M; Li L; Godbout R
Redox Biol; 2024 Feb; 69():102988. PubMed ID: 38096740
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]